The Science: How Microdosing Actually Works in the Brain
A research-backed map of how microdosing actually works — the molecular mechanisms, the brain network effects, and the limits of what we currently know.
Most of what gets written about microdosing online is either marketing or vibes. The Microdose Movement tries to do something different. The Science pillar is a research-backed map of what is actually happening when you take a low dose of psilocybin — what the molecule does, what the brain does in response, what the early clinical research has found, and what is still genuinely unknown.
This is not the place for personal stories or protocol guidance. The Practice pillar covers protocols. The Root pillar covers history. The Science pillar covers mechanism, evidence, and the honest limits of what the field currently knows. If you want to understand the how and the why underneath the practice, this is where to start.
How this pillar is organized
Each page in The Science pillar focuses on one specific concept and explains it in plain language without dumbing it down. Every page links out to the original peer-reviewed research, names the scientists who did the work, and includes a “what we still do not know” section because the science is real but it is also young. Pretending the picture is more settled than it is would be its own kind of dishonesty.
The pages are designed to be read in any order. If you are trying to understand a specific concept, jump straight to the page on that concept. If you want the full picture, the recommended reading order is below.
Recommended reading order
Start here
- The Default Mode Network: The Brain System Psilocybin Quiets — the most consequential single concept in modern psychedelic neuroscience. The brain system that runs your inner narrator and what happens when psilocybin temporarily turns it down. This is the page to read if you only read one.
Then the molecular pieces
- The 5-HT2A Serotonin Receptor: How Psilocybin and SSRIs Compete for the Same Site — the specific receptor psilocin binds to and the gateway through which everything else happens
- Psilocybin vs Psilocin: How Your Body Converts One to the Other — the chemistry of what the mushroom produces versus what your brain actually responds to
Then the brain change layer
- Psilocybin and Neuroplasticity: What the Research Actually Shows — the dendritic spine growth, the BDNF story, and the rapid plasticity window the medicine opens
Then the practical pharmacology
- SSRIs and Psilocybin: Combination, Risks, and the Honest Tapering Conversation — what happens when you combine antidepressants with psilocybin and why most people on SSRIs feel little from a microdose
- Why You Feel Numb on Antidepressants: The Science of SSRI Emotional Blunting — the related but distinct phenomenon of long-term SSRI side effects
- Serotonin Syndrome and Psychedelics: Which Combinations Actually Carry Risk — the safety conversation about combining serotonergic compounds, with the evidence-based version of what is actually risky
Then the people and places
- James Fadiman and the Modern Microdosing Protocol — the researcher most responsible for the protocol most beginners use
- Imperial College London Psilocybin Research — the team that produced more of the foundational science of the modern field than any other institution
What this pillar is not
A few things to be clear about.
Not medical advice. The pages in this pillar are educational, not clinical. They link out to original research and explain mechanism. They do not tell you what to do with your body. For practical guidance about dosing and protocols, see The Practice pillar.
Not a substitute for reading the original studies. Every page summarizes research. The summaries are accurate as of the publication date. The original papers are linked from each page and are the canonical sources. If you want to evaluate the evidence yourself, read those.
Not settled science. The modern psilocybin research field is rapidly evolving. Some of what we currently believe will turn out to be wrong. Some of what we currently consider speculative will turn out to be central. Each page includes an honest “what we still do not know” section because that uncertainty is part of the actual scientific picture.
Not pro-microdose propaganda. The Microdose Movement believes microdosing is a useful tool for the right person at the right time, with the right practice around it. We are not interested in claims that exceed what the evidence supports. When the evidence is mixed or weak, the pages say so.
How this pillar connects to the rest of the site
The Science pillar is the reference layer. Almost every article in The Practice links back into this pillar for the underlying mechanism. The same is true of the Archetype quiz results — when a result page tells you something about how psilocybin affects mood, anxiety, focus, or social presence, the actual research backing that claim lives here.
Think of The Practice as the “what to do” layer and The Science as the “why it works” layer. Both are necessary. Neither is complete on its own.
Limitless by nature, but only because the science finally caught up.
The Microdose Movement is an educational community, not a medical provider. Nothing on these pages is medical advice. If you are in crisis, contact your local emergency services or a crisis helpline.
All science articles
-
Imperial College Psilocybin Research: What the Studies Have Found
A summary of the most influential research center in modern psychedelic science — the Imperial College London team that produced the first fMRI study of psilocybin and the first head-to-head trial against an SSRI.
Read → -
James Fadiman: The Father of the Modern Microdosing Protocol
Dr. James Fadiman is the researcher most responsible for the modern microdosing protocol. Here is who he is, what his research has actually documented, and where the protocol came from.
Read → -
Memory Reconsolidation and Trauma: How Psilocybin May Help
A research-backed look at memory reconsolidation — the neuroscience that explains how trauma memories can be modified, and how psilocybin may enhance this window for healing work.
Read → -
Microdosing for ADHD: What the Research Shows
A research-backed look at what the science actually shows about microdosing for ADHD — the small but growing evidence base, the proposed mechanisms, and the limits of what we currently know.
Read → -
Microdosing for Depression and Anxiety: What the Research Shows
A research-backed look at what the published science actually shows about microdosing for depression and anxiety — the major studies, the limits of the data, and what the field still does not know.
Read → -
Psilocybin and Neuroplasticity: How the Brain Rewires Itself
How psilocybin promotes growth of new neural connections in the brain — what the rodent and human research shows, and the limits of what we currently know.
Read → -
Psilocybin vs Psilocin: The Active Compound, Explained
Psilocybin and psilocin are two different molecules. One is in the mushroom. The other is what your body actually responds to. Here is how the conversion works and why it matters.
Read → -
Serotonin Syndrome and Psychedelics: The Real Risks
A clear breakdown of serotonin syndrome — what it is, what causes it, which psychedelic combinations actually carry real risk, and how to recognize the symptoms.
Read → -
SSRI Emotional Blunting: Why Antidepressants Make You Feel Numb
Emotional blunting is one of the most common and least talked-about side effects of long-term SSRI use. Here is what causes it, how common it is, and what the research says about reversing it.
Read → -
SSRIs and Psilocybin: Combination Risks and the Tapering Conversation
What the research actually shows about combining SSRIs and psilocybin, why most people on SSRIs feel little from microdoses, and how to think about tapering safely if you want to start a microdosing practice.
Read → -
The 5-HT2A Serotonin Receptor: How Psilocybin and SSRIs Compete
A clear explanation of the 5-HT2A serotonin receptor — what it does, why it is the molecular target of psilocybin and other classic psychedelics, and how SSRIs interact with the same system.
Read → -
The Default Mode Network: How Psilocybin Quiets Your Inner Static
A clear, research-backed explanation of the Default Mode Network — what it is, why it matters in depression and anxiety, and how psilocybin temporarily quiets it.
Read →